184 related articles for article (PubMed ID: 16388850)
1. Aven overexpression: association with poor prognosis in childhood acute lymphoblastic leukemia.
Choi J; Hwang YK; Sung KW; Kim DH; Yoo KH; Jung HL; Koo HH
Leuk Res; 2006 Aug; 30(8):1019-25. PubMed ID: 16388850
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic significance of the apoptotic genes BCL2L13, Livin, and CASP8AP2 in childhood acute lymphoblastic leukemia.
Yang YL; Lin SR; Chen JS; Lin SW; Yu SL; Chen HY; Yen CT; Lin CY; Lin JF; Lin KH; Jou ST; Hu CY; Chang SK; Lu MY; Chang HH; Chang WH; Lin KS; Lin DT
Leuk Res; 2010 Jan; 34(1):18-23. PubMed ID: 20109966
[TBL] [Abstract][Full Text] [Related]
3. High frequency of t(12;21)(p13;q22) in children with acute lymphoblastic leukemia and known clinical outcome in southern Brazil.
Veiga LB; Cóser VM; Cavalli LR; Cavalli IJ; Rodrigues JN; Pereira WV; Pereira DV; Lafayette TC; Villalba BT; Moreira ME; Haddad BR; de Souza Fonseca Ribeiro EM
Leuk Res; 2004 Oct; 28(10):1033-8. PubMed ID: 15289014
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms.
Eißmann M; Melzer IM; Fernández SB; Michel G; Hrabě de Angelis M; Hoefler G; Finkenwirth P; Jauch A; Schoell B; Grez M; Schmidt M; Bartholomae CC; Newrzela S; Haetscher N; Rieger MA; Zachskorn C; Mittelbronn M; Zörnig M
Oncogene; 2013 May; 32(20):2586-91. PubMed ID: 22751129
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of cytogenetic abnormalities of chromosome arm 12p in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Heerema NA; Sather HN; Sensel MG; Lee MK; Hutchinson R; Nachman JB; Lange BJ; Steinherz PG; Bostrom B; Gaynon PS; Uckun FM
Cancer; 2000 Apr; 88(8):1945-54. PubMed ID: 10760773
[TBL] [Abstract][Full Text] [Related]
6. Low mRNA expression of the apoptosis-related genes CASP3, CASP8, and FAS is associated with low induction treatment response in childhood acute lymphoblastic leukemia (ALL).
Mata JF; Silveira VS; Mateo EC; Cortez MA; Queiroz RG; Yunes JA; Lee ML; Toledo SR; Petrilli AS; Brandalise SR; Tone LG; Scrideli CA
Pediatr Blood Cancer; 2010 Jul; 55(1):100-7. PubMed ID: 20232432
[TBL] [Abstract][Full Text] [Related]
7. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
8. Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence.
Wu S; Gessner R; von Stackelberg A; Kirchner R; Henze G; Seeger K
Cancer; 2005 Mar; 103(5):1054-63. PubMed ID: 15651075
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel molecular prognostic markers for paediatric T-cell acute lymphoblastic leukaemia.
Gottardo NG; Hoffmann K; Beesley AH; Freitas JR; Firth MJ; Perera KU; de Klerk NH; Baker DL; Kees UR
Br J Haematol; 2007 May; 137(4):319-28. PubMed ID: 17456054
[TBL] [Abstract][Full Text] [Related]
10. Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features.
de Oliveira JC; Scrideli CA; Brassesco MS; Morales AG; Pezuk JA; Queiroz Rde P; Yunes JA; Brandalise SR; Tone LG
Leuk Res; 2012 Mar; 36(3):293-8. PubMed ID: 22099053
[TBL] [Abstract][Full Text] [Related]
11. Outcome of ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: frequent late relapses but good overall survival.
Forestier E; Heyman M; Andersen MK; Autio K; Blennow E; Borgström G; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kerndrup G; Nordgren A; Rosenquist R; Swolin B; Johansson B; ; ;
Br J Haematol; 2008 Mar; 140(6):665-72. PubMed ID: 18241254
[TBL] [Abstract][Full Text] [Related]
12. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and cytogenetic features in childhood acute lymphoblastic leukemia with 1; 19 translocation].
Sikano T; Ishikawa Y; Konno M; Hatayama Y; Nakadate H; Hatae Y; Takeda T
Rinsho Ketsueki; 1990 Jun; 31(6):793-8. PubMed ID: 2214170
[TBL] [Abstract][Full Text] [Related]
14. Correlation between high vascular endothelial growth factor-A serum levels and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: a report from Children's Oncology Group Study CCG-1962.
Avramis IA; Panosyan EH; Dorey F; Holcenberg JS; Avramis VI;
Clin Cancer Res; 2006 Dec; 12(23):6978-84. PubMed ID: 17145817
[TBL] [Abstract][Full Text] [Related]
15. Expression of interleukin-10 splicing variants is a positive prognostic feature in relapsed childhood acute lymphoblastic leukemia.
Wu S; Gessner R; Taube T; von Stackelberg A; Henze G; Seeger K
J Clin Oncol; 2005 May; 23(13):3038-42. PubMed ID: 15860861
[TBL] [Abstract][Full Text] [Related]
16. Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia.
Choi J; Hwang YK; Sung KW; Lee SH; Yoo KH; Jung HL; Koo HH; Kim HJ; Kang HJ; Shin HY; Ahn HS
Blood; 2007 Jan; 109(2):471-7. PubMed ID: 16990595
[TBL] [Abstract][Full Text] [Related]
17. [Hyperdiploidy (greater than 50 chromosomes) has the most favorable prognosis among the major karyotypic subgroups of childhood acute lymphoblastic leukemia].
Shikano T; Ishikawa Y; Kobayashi R; Konno M; Hatayama Y; Nakadate H; Hatae Y; Takeda T
Rinsho Ketsueki; 1990 Mar; 31(3):308-14. PubMed ID: 2366333
[TBL] [Abstract][Full Text] [Related]
18. Expression of late cell cycle genes and an increased proliferative capacity characterize very early relapse of childhood acute lymphoblastic leukemia.
Kirschner-Schwabe R; Lottaz C; Tödling J; Rhein P; Karawajew L; Eckert C; von Stackelberg A; Ungethüm U; Kostka D; Kulozik AE; Ludwig WD; Henze G; Spang R; Hagemeier C; Seeger K
Clin Cancer Res; 2006 Aug; 12(15):4553-61. PubMed ID: 16899601
[TBL] [Abstract][Full Text] [Related]
19. Prediction of relapse in paediatric pre-B acute lymphoblastic leukaemia using a three-gene risk index.
Hoffmann K; Firth MJ; Beesley AH; Freitas JR; Ford J; Senanayake S; de Klerk NH; Baker DL; Kees UR
Br J Haematol; 2008 Mar; 140(6):656-64. PubMed ID: 18302714
[TBL] [Abstract][Full Text] [Related]
20. Identification of prognosis markers in pediatric high-risk acute lymphoblastic leukemia.
Al-Lamki Z; Wali YA; Wasifuddin SM; Zachariah M; Al-Mjeni R; Li C; Muralitharan S; Al-Kharusi K; Gunaratne P; Peterson L; Gibbs R; Gingras MC; Margolin JF
Pediatr Hematol Oncol; 2005; 22(7):629-43. PubMed ID: 16166056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
